
Emagix reduces vision loss risk by detecting retinal vascular leakage noninvasively, enabling earlier treatment without dye injections. The company uses generative AI and image-analysis algorithms to simulate invasive dye-based exams from standard noninvasive retinal and MRI imaging. Its product is an AI diagnostic image-analysis platform serving clinicians and eye-care providers as a clinical software support tool. Emagix focuses on vascular health assessment in retinal and MRI images to enable broader screening and timely intervention to prevent vision-related complications.

Emagix reduces vision loss risk by detecting retinal vascular leakage noninvasively, enabling earlier treatment without dye injections. The company uses generative AI and image-analysis algorithms to simulate invasive dye-based exams from standard noninvasive retinal and MRI imaging. Its product is an AI diagnostic image-analysis platform serving clinicians and eye-care providers as a clinical software support tool. Emagix focuses on vascular health assessment in retinal and MRI images to enable broader screening and timely intervention to prevent vision-related complications.